Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations, Regulatory Approvals and Increasing Disease Prevalence Present Growth Opportunities by GBIResearch

VIEWS: 50 PAGES: 102

Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations, Regulatory Approvals and Increasing Disease Prevalence Present Growth Opportunities, provides key data, information and analysis on the global Cardiac Rhythm Management (CRM) devices market. The report provides market landscape, competitive landscape and market trends information on three CRM devices market categories – Cardiac Resynchronization Therapy (CRT) devices, Implantable Cardioverter Defibrillator (ICD) devices, and pacemakers. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on market dynamics. The report also reviews the competitive landscape, through major acquisitions and mergers in the last six years, and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

More Info
									         Cardiac Rhythm Management Devices Market to 2017 -
         Technological Innovations, Regulatory Approvals and
            Increasing Disease Prevalence Present Growth
                            Opportunities
 Reference Code: GBIME0059MR                                                                                             Publication Date: March 2012


                                     The Global Cardiac Rhythm Management Devices Market is Forecast to Reach $1.4 Billion in
The global market for                2017
Cardiac Rhythm
Management (CRM)                       Cardiac Rhythm Management Devices Market, Global, Revenue ($m), 2010-2017
devices is forecast to
reach $15.1 billion by
                                                           16,000
2017, increasing at a
Compound Annual Growth                                                            CAGR(2010-2017): 4.2%
Rate (CAGR) of 4.2%                                        14,000
between 2010 and 2017
                                                           12,000


                                                           10,000
                                            Revenue ($m)




                                                            8,000


                                                            6,000


                                                            4,000


                                                            2,000


                                                               0
                                                                              2010                                             2017


                                       Source: GBI Research, Annual Reports, SEC Filings, Investor Presentations, Earning Call Transcripts, News and Press
                                       Releases, Scientific Journals, Trade Associations, Interviews with Industry Experts and Key Opinion Leaders (KOLs)




                                     The global market for Cardiac Rhythm Management (CRM) devices is forecast to reach $15.1
                                     billion by 2017, increasing at a Compound Annual Growth Rate (CAGR) of 4.2% between 2010 and
                                     2017. The global CRM devices market consists of Cardiac Resynchronization Therapy (CRT)
                                     devices, Implantable Cardioverter Defibrillators (ICDs) and pacemaker systems. An aging and
                                     increasing population of patients with cardiac arrhythmias and Congestive Heart Failure (CHF) are
                                     expected to drive demand in the global CRM devices market in the future. The market is also
                                     expected to be driven by the development of technologically advanced CRM devices, including
                                     devices which are miniaturized, Magnetic Resonance Imaging (MRI) compatible, and wireless.
                                     Extensive clinical studies have established the use of technologically advanced CRM devices for a
                                     more diverse range of medical conditions, which has also led to an increase in the adoption of
                                     CRM devices, creating growth within the global CRM devices market. The support of new product
                                     launches by regulatory bodies such as the US Food and Drugs Administration (FDA) and recent
                                     healthcare reforms in various countries have also affected the market growth of CRM devices.




Cardiac Rhythm Management Devices Market to 2017 -                                                                GBIME0059MR /Published MAR 2012
Technological Innovations, Regulatory Approvals and Increasing                                                                                   Page 1
Disease Prevalence Present Growth Opportunities                               © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                              reproduced, shared or resold in any form
                                     The US is the Biggest Market for Cardiac Rhythm Management Devices
The US represents the
biggest market for CRM                 Cardiac Rhythm Management Devices Market, Global, Geographic Contribution (%), 2010
devices, and contributed
about $5.6 billion or 49%
towards the global market
in 2010




                                                                                                                               US
                                                                 Others                                                       49%
                                                                  51%




                                       Source: GBI Research, Annual Reports, SEC Filings, Investor Presentations, Earning Call Transcripts, News and Press
                                       Releases, Scientific Journals, Trade Associations, Interviews with Industry Experts and Key Opinion Leaders (KOLs)




                                     The US represents the biggest market for CRM devices, and contributed about $5.6 billion or 49%
                                     towards the global market in 2010. The CRM devices market in the US is forecast to reach a
                                     market value of $6.5 billion in 2017.
                                     Factors such as the aging and increasing patient population, growing patient awareness, growing
                                     demand for CRM device-based procedures, and higher availability due to a significant number of
                                     heart care centers throughout the country are responsible for the US being the biggest market for
                                     CRM devices. Various clinical trials are conducted by manufacturers in the US in order to provide
                                     robust clinical data on the safety and efficacy of the devices. This has enabled their use in
                                     expanded indications, and has also led to an increased adoption of CRM devices in the market.
                                     The market launch and approval of unique and technologically advanced products will further drive
                                     demand for CRM devices in the future.




Cardiac Rhythm Management Devices Market to 2017 -                                                                GBIME0059MR /Published MAR 2012
Technological Innovations, Regulatory Approvals and Increasing                                                                                   Page 2
Disease Prevalence Present Growth Opportunities                               © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                              reproduced, shared or resold in any form
                                     Medtronic, Inc. was the Leading Company in the Global Cardiac Rhythm Management
In 2010, Medtronic, Inc.             Devices Market in 2010
was the leader in the
global CRM devices                     Cardiac Rhythm Management Devices Market, Global, Company Share (%), 2010
market with a 44% share
                                                                                    Others
                                                                                     13%
                                                                         Boston
                                                                        Scientific                             Medtronic, Inc.
                                                                       Corporation                                 44%
                                                                          17%




                                                                              St. Jude
                                                                             Medical, Inc.
                                                                                26%

                                       Source: GBI Research, Annual Reports, SEC Filings, Investor Presentations, Earning Call Transcripts, News and Press
                                       Releases, Scientific Journals, Trade Associations, Interviews with Industry Experts and Key Opinion Leaders (KOLs)




                                     In 2010, Medtronic, Inc. was the leader in the global CRM devices market with a 44% share. This
                                     was followed by St. Jude Medical, Inc. & Co. with a 26% share and Boston Scientific Corporation
                                     with a 17% market share. Other significant players in this market include Sorin S.p.A, BIOTRONIK
                                     SE & Co. KG, and ABIOMED. The competitive landscape in the global CRM devices market is
                                     characterized by the launch and development of new products incorporated with unique innovative
                                     technologies, industry consolidation, pricing pressures from Group Purchasing Organizations
                                     (GPOs), and constant technology upgradation. This has led to a constant downward pricing of
                                     CRM devices across various geographies. Manufacturers are engaged in developing innovative
                                     technologies that offer additional benefits to their products, and conducting clinical studies to prove
                                     the cost effectiveness of their devices in order to gain third party reimbursements to produce the
                                     devices cheaper, driving their adoption in the market.
                                     Development of Technologically Advanced Products and Increasing Patient Population to
                                     Better the Adoption Rates of Cardiac Rhythm Management Devices Market in the Future
                                     The global CRM devices market was valued at $11.3 billion in 2010, and is expected to grow at a
                                     CAGR of 4.2% to reach a market value of $15.1 billion in 2017. The market is expected to be
                                     driven by an increasing patient population, and the development and launch of technologically
                                     advanced products in the future. The presence of around 61 products in the pipeline, including first-
                                     in-market product developments, indicates an increasing focus by manufacturers to invest in
                                     Research and Development (R&D) in this market. Recent new product launches include MRI
                                     compatible and wireless CRM devices which offer remote patient monitoring. The entry of remote
                                     monitoring capabilities in implanted pacemakers and defibrillators due to the benefits they provide
                                     to patients and physicians, will lead to a significant growth of the demand for CRM devices in the
                                     future.
                                     The increasing incidence rate of Cardiovascular Diseases (CVDs), such as heart failure and
                                     cardiac arrhythmia, is driving the demand for CRM devices and causing an increase in adoption
                                     rates and market growth. The World Health Organization (WHO) estimates that by 2030,
                                     approximately around 23.6 million people will have died from CVDs. The risk factors for CVDs
                                     include hypertension, diabetes, obesity, and the use of tobacco. Aging is another factor which is
                                     associated with the increasing CVD patient population.
                                     The guidelines from the American Heart Association (AHA) and American College of Cardiology
                                     recommend the timely implantation of these devices in heart failure patients, since they carry a
                                     significant risk of unexpected cardiac arrhythmias or associated cardiac arrests. The ‘Improve the
                                     Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting’ (IMPROVE HF) study of
                                     heart patients in the US also recommends that a higher level of medical attention should be given
                                     to women who suffer chronic heart failures, and children with congenital heart defects.




Cardiac Rhythm Management Devices Market to 2017 -                                                                GBIME0059MR /Published MAR 2012
Technological Innovations, Regulatory Approvals and Increasing                                                                                   Page 3
Disease Prevalence Present Growth Opportunities                               © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                              reproduced, shared or resold in any form
                                     1         Table of Contents
                                     1   Table of Contents ........................................................................................................................ 4
                                         1.1    List of Tables..................................................................................................................... 6
                                         1.2    List of Figures ................................................................................................................... 8
                                     2   Introduction .................................................................................................................................. 9
                                         2.1    GBI Research Report Guidance ..................................................................................... 10
                                     3   Cardiac Rhythm Management Devices - Market Characterization ............................................ 11
                                         3.1    Global Cardiac Rhythm Management Devices Market, Revenue ($m), 2003-2010 ........ 11
                                         3.2    Global Cardiac Rhythm Management Devices Market, Revenue Forecast ($m), 2010 -
                                                2017 ................................................................................................................................ 12
                                         3.3    Global Cardiac Rhythm Management Devices, Market Dynamics .................................. 13
                                            3.3.1      Market Drivers ......................................................................................................... 14
                                            3.3.2      Market Restraints .................................................................................................... 27
                                         3.4    Global Cardiac Rhythm Management Devices Market, Key Company Share (%), 2010 30
                                     4   Global Cardiac Rhythm Management Devices Market - Category Analysis and Forecasts ...... 31
                                         4.1    Cardiac Resynchronization Therapy Devices ................................................................. 31
                                            4.1.1      Cardiac Resynchronization Therapy Devices Market, Global, Revenue ($m), 2003-
                                                       2010 ........................................................................................................................ 31
                                            4.1.2      Cardiac Resynchronization Therapy Devices Market, Global, Revenue Forecast
                                                       ($m), 2010-2017 ...................................................................................................... 33
                                            4.1.3      Cardiac Resynchronization Therapy Devices, Market Dynamics ............................ 34
                                         4.2    Implantable Cardioverter Defibrillators ............................................................................ 37
                                            4.2.1      Implantable Cardioverter Defibrillators Market, Global, Revenue ($m), 2003-2010. 37
                                            4.2.2      Implantable Cardioverter Defibrillators Market, Global, Revenue Forecast ($m),
                                                       2010-2017 ............................................................................................................... 39
                                            4.2.3      Implantable Cardioverter Defibrillators - Market Dynamics ...................................... 40
                                         4.3    Pacemakers .................................................................................................................... 43
                                            4.3.1      Pacemakers Market, Global, Revenue ($m), 2003-2010......................................... 43
                                            4.3.2      Pacemakers Market, Global, Revenue Forecast ($m), 2010-2017 .......................... 44
                                            4.3.3      Pacemakers - Market Dynamics .............................................................................. 45
                                     5   Global Cardiac Rhythm Management Devices Market - Country Analysis and Forecasts, 2003-
                                         2017 .......................................................................................................................................... 50
                                         5.1    Cardiac Rhythm Management Devices Market, the US, Revenue ($m), 2003-2010 ...... 50
                                         5.2    Cardiac Rhythm Management Devices Market, the US, Revenue ($m), 2010-2017 ...... 51
                                         5.3    Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2003-2010..... 52
                                         5.4    Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2010-2017..... 53
                                         5.5    Cardiac Rhythm Management Devices Market, the UK, Revenue ($m), 2003-2010 ...... 54
                                         5.6    Cardiac Rhythm Management Devices Market, the UK, Revenue ($m), 2010-2017 ...... 55
                                         5.7    Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2003-2010 .. 56
                                         5.8    Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2010-2017 .. 57
                                         5.9    Cardiac Rhythm Management Devices Market, France, Revenue ($m), 2003-2010 ...... 58
                                         5.10 Cardiac Rhythm Management Devices Market, France, Revenue ($m), 2010-2017 ...... 59
                                         5.11 Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), 2003-2010........... 60
                                         5.12 Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), 2010-2017........... 61
                                         5.13 Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), 2003-2010 ........ 62
                                         5.14 Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), 2010-2017 ........ 63
                                         5.15 Cardiac Rhythm Management Devices Market, Japan, Revenue ($m), 2003-2010 ....... 64
                                         5.16 Cardiac Rhythm Management Devices Market, Japan, Revenue ($m), 2010-2017 ....... 65
                                         5.17 Cardiac Rhythm Management Devices Market, China, Revenue ($m), 2003-2010 ........ 66
                                         5.18 Cardiac Rhythm Management Devices Market, China, Revenue ($m), 2010-2017 ........ 67
                                         5.19 Cardiac Rhythm Management Devices Market, India, Revenue ($m), 2003-2010 ......... 68
                                         5.20 Cardiac Rhythm Management Devices Market, India, Revenue ($m), 2010-2017 ......... 69
                                         5.21 Cardiac Rhythm Management Devices Market, Australia, Revenue ($m), 2003-2010 ... 70
                                         5.22 Cardiac Rhythm Management Devices Market, Australia, Revenue ($m), 2010-2017 ... 71
                                         5.23 Cardiac Rhythm Management Devices Market, Brazil, Revenue ($m), 2003-2010 ........ 72

Cardiac Rhythm Management Devices Market to 2017 -                                                                         GBIME0059MR /Published MAR 2012
Technological Innovations, Regulatory Approvals and Increasing                                                                                            Page 4
Disease Prevalence Present Growth Opportunities                                        © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                                       reproduced, shared or resold in any form
                                       5.24 Cardiac Rhythm Management Devices Market, Brazil, Revenue ($m), 2010-2017 ........ 73
                                     6 Global Cardiac Rhythm Management Devices Market - Competitive Assessment.................... 74
                                       6.1    Medtronic, Inc. ................................................................................................................ 74
                                          6.1.1    Key Marketed Products ........................................................................................... 75
                                          6.1.2    SWOT Analysis ....................................................................................................... 75
                                       6.2    St. Jude Medical, Inc....................................................................................................... 76
                                          6.2.1    Key Marketed Products ........................................................................................... 76
                                          6.2.2    SWOT Analysis ....................................................................................................... 77
                                       6.3    Boston Scientific Corporation .......................................................................................... 78
                                          6.3.1    Key Marketed Products ........................................................................................... 78
                                          6.3.2    SWOT Analysis ....................................................................................................... 79
                                       6.4    Sorin S.p.A. ..................................................................................................................... 80
                                          6.4.1    Key Marketed Products ........................................................................................... 80
                                          6.4.2    SWOT Analysis ....................................................................................................... 81
                                       6.5    BIOTRONIK SE & Co. KG .............................................................................................. 82
                                          6.5.1    Key Marketed Products ........................................................................................... 82
                                          6.5.2    SWOT Analysis ....................................................................................................... 83
                                     7 Global Cardiac Rhythm Management Devices Market - Product Pipeline Analysis................... 84
                                       7.1    Cardiac Resynchronization Therapy Devices ................................................................. 85
                                          7.1.1    Key Pipeline Products ............................................................................................. 85
                                       7.2    Implantable Cardioverter Defibrillators ............................................................................ 86
                                          7.2.1    Key Pipeline Products ............................................................................................. 87
                                       7.3    Pacemakers .................................................................................................................... 88
                                          7.3.1    Key Pipeline Products ............................................................................................. 88
                                     8 Global Cardiac Rhythm Management Devices Market - Consolidation Landscape ................... 90
                                       8.1    Cardiac Rhythm Management Devices Market, Number of Deals, Global, 2006-2010... 90
                                       8.2    Key Acquisition Deals ..................................................................................................... 91
                                          8.2.1    St. Jude Medical to invest in Nanostim .................................................................... 92
                                          8.2.2    Heart Force Medical acquires patent from Dr. Frank I. Marcus ............................... 92
                                          8.2.3    Boston Scientific completes acquisition of Atritech .................................................. 92
                                          8.2.4    Medtronic acquires Ablation Frontiers ..................................................................... 93
                                          8.2.5    St. Jude Medical acquires EP MedSystems ............................................................ 93
                                          8.2.6    Boston Scientific acquires Remon Medical.............................................................. 93
                                       8.3    Key Partnership Deals .................................................................................................... 94
                                          8.3.1    LETI forms partnership with Sorin, TIMA, Cedrat Technologies, Tronics and EASII
                                                   IC ............................................................................................................................. 95
                                          8.3.2    Hansen Medical signs an agreement with St. Jude Medical.................................... 95
                                          8.3.3    Masimo Enters into licensing agreement with GS Electro Medical Equipment ........ 95
                                          8.3.4    AorTech International expands licensing agreement with St. Jude Medical ............ 96
                                          8.3.5    Philips Enters into Co-Development Agreement with Bard Electrophysiology ......... 96
                                          8.3.6    Boston Scientific enters into an agreement with GE Healthcare.............................. 96
                                     9 Appendix ................................................................................................................................... 97
                                       9.1    Definitions ....................................................................................................................... 97
                                          9.1.1    Cardiac Rhythm Management devices .................................................................... 97
                                       9.2    Acronyms ........................................................................................................................ 98
                                       9.3    Research Methodology ................................................................................................... 99
                                          9.3.1    Secondary Research ............................................................................................... 99
                                          9.3.2    Primary Research .................................................................................................. 100
                                          9.3.3    Models ................................................................................................................... 100
                                          9.3.4    Forecasts ............................................................................................................... 100
                                          9.3.5    Expert Panels ........................................................................................................ 101
                                       9.4    Contact Us .................................................................................................................... 101
                                       9.5    Disclaimer ..................................................................................................................... 101
                                       9.6    Sources ......................................................................................................................... 101



Cardiac Rhythm Management Devices Market to 2017 -                                                                       GBIME0059MR /Published MAR 2012
Technological Innovations, Regulatory Approvals and Increasing                                                                                          Page 5
Disease Prevalence Present Growth Opportunities                                      © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                                     reproduced, shared or resold in any form
                                     1.1     List of Tables
                                     Table 1:    Cardiac Rhythm Management Devices Market, Global, Revenue ($m), 2003 - 2010 .... 11
                                     Table 2:    Cardiac Rhythm Management Devices Market, Global, Revenue ($m), 2010 - 2017 .... 12
                                     Table 3:    Cardiac Rhythm Management Devices, Pipeline Products with Miniature Design and
                                                 Extended Battery-Life..................................................................................................... 15
                                     Table 4:    Cardiac Rhythm Management Devices, MRI Compatible Products ............................... 16
                                     Table 5:    Cardiac Rhythm Management Devices, Wireless/Remote Patient Monitoring Compatible
                                                 Products ......................................................................................................................... 16
                                     Table 6:    Cardiac Rhythm Management Devices, Technological Advancements ......................... 17
                                     Table 7:    Heart Failure, Prevalence (Million), the US, 2002-2010 ................................................. 19
                                     Table 8:    Incidence of Cardiovascular Disease (per 1000), the US, 2008 ..................................... 20
                                     Table 9:    Percentage of Population Aged 65 Years and Older, by Country, 2005-2015 ............... 21
                                     Table 10:   Increasing Awareness of Cardiovascular Diseases: Awareness Campaigns................. 22
                                     Table 11:   Cardiac Rhythm Management Devices Market, CAGR Comparison (%), 2010-2017 .... 23
                                     Table 12:   Emerging Markets Contribution, Global, 2009-2010 ...................................................... 24
                                     Table 13:   Landmark Clinical Trials for Cardiac Rhythm Management Devices.............................. 25
                                     Table 14:   Technologically Advanced Products Approved in 2011 ................................................. 26
                                     Table 15:   Inpatient Prospective Payment System, Change in Payments, (%), the US, (2009 -
                                                 2012) .............................................................................................................................. 27
                                     Table 16:   Number of Recalls, Cardiac Rhythm Management Devices, 2008-2011 ....................... 28
                                     Table 17:   Cardiac Rhythm Management Devices Market, Global, Key Company Revenues ($m),
                                                 2010 ............................................................................................................................... 30
                                     Table 18:   Cardiac Resynchronization Therapy Devices Market, Global, Revenue ($m), 2003 -
                                                 2010 ............................................................................................................................... 32
                                     Table 19:   Cardiac Resynchronization Therapy Devices Market, Global, Revenue ($m), 2010-2017
                                                 ....................................................................................................................................... 33
                                     Table 20:   Cardiac Resynchronization Therapy Devices, Pipeline Products................................... 35
                                     Table 21:   Cardiac Resynchronization Devices Market, List of Device Recalls, 2007-2010 ........... 36
                                     Table 22:   Implantable Cardioverter Defibrillators Market, Global, Revenue ($m), 2003-2010 ....... 38
                                     Table 23:   Implantable Cardioverter Defibrillators Market, Global, Revenue ($m), 2010-2017 ....... 39
                                     Table 24:   Implantable Cardioverter Defibrillators, Number of Procedures, 2010-2016 .................. 40
                                     Table 25:   Implantable Cardioverter Defibrillators, Pipeline Products ............................................. 41
                                     Table 26:   Implantable Cardioverter Defibrillators Market, List of Device Recalls, 2004-2010 ........ 42
                                     Table 27:   Pacemakers Market, Global, Revenue ($m), 2003-2010 ............................................... 43
                                     Table 28:   Pacemakers Market, Global, Revenue ($m), 2010-2017 ............................................... 44
                                     Table 29:   Pacemaker Devices Market in Emerging Economies Compared with Developed
                                                 Economies ..................................................................................................................... 46
                                     Table 30:   Dual Chamber Pacemakers, Declining Average Selling Prices in Developed Economies,
                                                 ($), 2008-2010................................................................................................................ 47
                                     Table 31:   Single Chamber Pacemakers, Declining Average Selling Prices in Developed
                                                 Economies, ($), 2008-2010 ............................................................................................ 48
                                     Table 32:   Cardiac Rhythm Management Devices Market, the US, Revenue ($m), 2003-2010 ..... 50
                                     Table 33:   Cardiac Rhythm Management Devices Market, the US, Revenue ($m), 2010-2017 ..... 51
                                     Table 34:   Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2003-2010 .... 52
                                     Table 35:   Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2010-2017 .... 53
                                     Table 36:   Cardiac Rhythm Management Devices Market, the UK, Revenue ($m), 2003-2010 ..... 54
                                     Table 37:   Cardiac Rhythm Management Devices Market, the UK, Revenue ($m), 2010- 2017 .... 55
                                     Table 38:   Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2003-2010.. 56
                                     Table 39:   Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2010-2017.. 57
                                     Table 40:   Cardiac Rhythm Management Devices Market, France, Revenue ($m), 2003-2010 ..... 58
                                     Table 41:   Cardiac Rhythm Management Devices Market, France, Revenue ($m), 2010-2017 ..... 59
                                     Table 42:   Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), 2003-2010 .......... 60
                                     Table 43:   Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), 2010-2017 .......... 61
                                     Table 44:   Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), 2003-2010 ....... 62
                                     Table 45:   Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), 2010-2017 ....... 63
                                     Table 46:   Cardiac Rhythm Management Devices Market, Japan, Revenue ($m), 2003-2010....... 64
                                     Table 47:   Cardiac Rhythm Management Devices Market, Japan, Revenue ($m), 2010-2017....... 65
                                     Table 48:   Cardiac Rhythm Management Devices Market, China, Revenue ($m), 2003-2010 ....... 66
                                     Table 49:   Cardiac Rhythm Management Devices Market, China, Revenue ($m), 2010-2017 ....... 67
                                     Table 50:   Cardiac Rhythm Management Devices Market, India, Revenue ($m), 2003-2010......... 68


Cardiac Rhythm Management Devices Market to 2017 -                                                                      GBIME0059MR /Published MAR 2012
Technological Innovations, Regulatory Approvals and Increasing                                                                                         Page 6
Disease Prevalence Present Growth Opportunities                                     © GBI Research. This report is a licensed product and is not to be copied,
                                                                                                                    reproduced, shared or resold in any form
                                     Table 51:   Cardiac Rhythm Management Devices Market, India, Revenue ($m), 2010-2017......... 69
                                     Table 52:   Cardiac Rhythm Management Devices Market, Australia, Revenue ($m), 2003-2010 .. 70
                                     Table 53:   Cardiac Rhythm Management Devices Market, Australia, Revenue ($m), 2010-2017 .. 71
                                     Table 54:   Cardiac Rhythm Management Devices Market, Brazil, Revenue ($m), 2003-2010 ....... 72
                                     Table 55:   Cardiac Rhythm Management Devices Market, Brazil, Revenue
								
To top